Abateas Industries Ltd Stock Price Today (NSE: ABATEAS)
Fundamental Score
Abateas Industries Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Abateas Industries Ltd share price today is ₹10.88, up +0.00% on NSE/BSE as of 2 June 2026. Abateas Industries Ltd (ABATEAS) is a Small-cap company in the Hospital sector with a market capitalisation of ₹263.20 (Cr). The 52-week high for ABATEAS share price is ₹26.20 and the 52-week low is ₹9.26. At a P/E ratio of 50.62x, ABATEAS is currently trading below its industry average P/E of 52.84x.
Abateas Industries Ltd Share Price Chart — NSE/BSE Historical Performance
Abateas Industries Ltd share price chart: -6.48% return over the past month. 52-week high ₹26.20, 52-week low ₹9.26.
Abateas Industries Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹9.86 | ₹10.23 | ₹9.86 | ₹10.10 | 7.00K (Cr) | |
| ₹10.84 | ₹10.84 | ₹10.15 | ₹10.29 | 14.00K (Cr) | |
| ₹10.25 | ₹10.59 | ₹10.04 | ₹10.10 | 6.71K (Cr) | |
| ₹9.81 | ₹10.15 | ₹9.37 | ₹10.00 | 27.32K (Cr) | |
| ₹9.26 | ₹10.19 | ₹9.26 | ₹9.37 | 1.57L (Cr) | |
| ₹10.16 | ₹10.70 | ₹9.60 | ₹10.25 | 11.16K (Cr) | |
| ₹10.34 | ₹10.97 | ₹10.03 | ₹10.37 | 5.12K (Cr) | |
| ₹10.00 | ₹10.40 | ₹10.00 | ₹10.30 | 10.42K (Cr) | |
| ₹10.43 | ₹10.43 | ₹10.13 | ₹10.39 | 20.30K (Cr) | |
| ₹10.42 | ₹10.45 | ₹10.22 | ₹10.27 | 1.08K (Cr) |
Abateas Industries Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹10.37 | ₹10.97 | ₹9.26 | ₹10.10 | -2.60% | |
| ₹10.95 | ₹12.69 | ₹10.00 | ₹10.37 | -5.30% | |
| ₹11.91 | ₹12.69 | ₹10.51 | ₹11.10 | -6.80% | |
| ₹11.40 | ₹15.20 | ₹10.01 | ₹12.09 | +6.05% | |
| ₹18.48 | ₹19.59 | ₹11.70 | ₹11.71 | -36.63% | |
| ₹17.55 | ₹19.05 | ₹15.91 | ₹17.50 | -0.28% | |
| ₹16.50 | ₹20.11 | ₹16.04 | ₹17.57 | +6.48% | |
| ₹16.33 | ₹17.90 | ₹14.78 | ₹16.34 | +0.06% | |
| ₹15.47 | ₹20.75 | ₹15.47 | ₹16.33 | +5.56% | |
| ₹25.71 | ₹26.20 | ₹16.28 | ₹16.28 | -36.68% | |
| ₹14.20 | ₹25.27 | ₹14.20 | ₹25.21 | +77.60% | |
| ₹10.10 | ₹13.52 | ₹10.10 | ₹13.52 | +33.86% |
AI Research Briefing
Powered by Gemini · 2026-04-22
Abateas is a micro-cap hope trade with stretched valuation and weak fundamentals; short it before the inevitable crash.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Abateas Industries' investment rating was downgraded to Strong Sell by Markets Mojo on March 23, 2026, citing deteriorating technical indicators and stretched valuation. ASYA, a promoter group entity, acquired a 4.5% stake through an off-market transaction involving 70,92,291 shares on March 23, 2026.
CORE STORY (THE REAL GAME)
Abateas is a micro-cap hospital play, but the market is treating it like a turnaround story despite weak fundamentals. The stock's price is detached from reality, driven by hope rather than concrete earnings or growth.
- Recent positive quarterly results are unsustainable
- Technical indicators are deteriorating
- Valuation is stretched relative to fundamentals
- Failure to sustain Q3 earnings momentum
- Negative news flow regarding hospital billing regulations
- Promoter selling
- Micro/SME cap: liquidity risk
- Weak long-term fundamentals
- Expensive valuation relative to fundamentals
Promoter group increased stake by 4.5%.
India is planning a cap on private hospital billing amid rising medical costs.
No Free Cash Flow
Expect a correction in the next 3-6 months as the market realizes the turnaround story is overblown. Short the stock and cover near its 52-week low.
Primary Thesis Risk
Reliance on a single quarter's results for a turnaround narrative.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Abateas Industries Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Abateas Industries Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ABATEAS across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Robust Profit Growth (13666.67%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Conservative Debt Levels (D/E: 0.05)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (16.71x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Premium Valuation Risk (P/E: 50.62x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Low Promoter Commitment (27.56%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Abateas Industries Ltd vs Hospital Peers
Peer Comparison - Hospital
Compare Abateas Industries Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Abateas Industries LtdAbateas Industr...Selected✓ ABATEAS • 531658 | 14.9/100 | ₹10.88₹11 | ₹263.20₹263.20 | 50.62Average 50.6 Average | — — | — — | 0.05Excellent 0.1 Excellent | — — | — — | 0.00% |
Max Healthcare Institute LtdMax Healthcare ... MAXHEALTH • 543220 | 69.1/100 | ₹993.45₹993 | ₹109416.28₹109416.28 | 77.65Average 77.7 Average | 12.72%Average 12.72% Average | 14.88%Average 14.88% Average | 0.33Excellent 0.3 Excellent | 80.50%Excellent 80.50% Excellent | 46.01%Excellent 46.01% Excellent | 0.13% |
Apollo Hospitals Enterprise LtdApollo Hospital... APOLLOHOSP • 508869 | 50.2/100 | ₹8272.50₹8273 | ₹104825.94₹104825.94 | 62.70Average 62.7 Average | 18.42%Good 18.42% Good | 16.64%Good 16.64% Good | 0.88Good 0.9 Good | 33.72%Excellent 33.72% Excellent | 14.15%Good 14.15% Good | 0.26% |
Fortis Healthcare LtdFortis Healthca... FORTIS • 532843 | 55.6/100 | ₹960.90₹961 | ₹68301.24₹68301.24 | 67.80Average 67.8 Average | 10.13%Average 10.13% Average | 11.96%Average 11.96% Average | 0.34Excellent 0.3 Excellent | 70.31%Excellent 70.31% Excellent | 10.93%Good 10.93% Good | 0.11% |
Narayana Hrudayalaya LtdNarayana Hruday... NH • 539551 | 62.2/100 | ₹1920.20₹1920 | ₹39051.19₹39051.19 | 45.92Average 45.9 Average | 24.22%Excellent 24.22% Excellent | 20.75%Excellent 20.75% Excellent | 0.58Good 0.6 Good | 43.49%Excellent 43.49% Excellent | 11.88%Good 11.88% Good | 0.24% |
Aster DM Healthcare LtdAster DM Health... ASTERDM • 540975 | 15.4/100 | ₹741.25₹741 | ₹34688.15₹34688.15 | 94.51Average 94.5 Average | 8.26%Poor 8.26% Poor | 10.68%Average 10.68% Average | 0.46Excellent 0.5 Excellent | -7.24%Poor -7.24% Poor | -13.71%Poor -13.71% Poor | 0.75% |
Global Health LtdGlobal Health L... MEDANTA • 543654 | 61/100 | ₹1207.80₹1208 | ₹33498.00₹33498.00 | 56.03Average 56.0 Average | 16.48%Good 16.48% Good | 19.74%Good 19.74% Good | 0.25Excellent 0.3 Excellent | 70.15%Excellent 70.15% Excellent | 19.73%Excellent 19.73% Excellent | 0.04% |
45.1/100 | ₹784.45₹784 | ₹27605.54₹27605.54 | 83.99Average 84.0 Average | 18.48%Good 18.48% Good | 15.00%Good 15.00% Good | 1.40Average 1.4 Average | 25.01%Excellent 25.01% Excellent | 22.01%Excellent 22.01% Excellent | 0.00% | |
Dr Agarwals Health Care LtdDr Agarwals Hea... AGARWALEYE • 544350 | 51.2/100 | ₹479.95₹480 | ₹16844.04₹16844.04 | 145.15Average 145.2 Average | 4.76%Poor 4.76% Poor | 9.99%Poor 9.99% Poor | 0.51Good 0.5 Good | 41.72%Excellent 41.72% Excellent | 26.38%Excellent 26.38% Excellent | 0.00% |
Rainbow Childrens Medicare Pvt LtdRainbow Childre... RAINBOW • 543524 | 54.6/100 | ₹1377.10₹1377 | ₹13410.38₹13410.38 | 52.84Average 52.8 Average | 17.43%Good 17.43% Good | 18.69%Good 18.69% Good | 0.54Good 0.5 Good | 33.66%Excellent 33.66% Excellent | 16.08%Excellent 16.08% Excellent | 0.23% |
36.4/100 | ₹659.95₹660 | ₹10474.40₹10474.40 | 296.22Average 296.2 Average | 5.14%Poor 5.14% Poor | 8.56%Poor 8.56% Poor | 1.92Average 1.9 Average | 19.34%Excellent 19.34% Excellent | 15.22%Excellent 15.22% Excellent | 0.00% | |
Top Hospital Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Max Healthcare Institute Ltd share price109416.28 Cr
- Apollo Hospitals Enterprise Ltd share price104825.94 Cr
- Fortis Healthcare Ltd share price68301.24 Cr
- Narayana Hrudayalaya Ltd share price39051.19 Cr
- Aster DM Healthcare Ltd share price34688.15 Cr
Abateas Industries Ltd PE Ratio History
Historical price-to-earnings ratio for ABATEAS — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2021 | ₹0.01 | ₹5.08 | 390.8x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Abateas Industries Ltd Quarterly Performance
Latest quarterly metrics for ABATEAS — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
N/A
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
13666.67%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Abateas Industries Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for ABATEAS — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Abateas Industries Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Abateas Industries Ltd (ABATEAS) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Abateas Industries Ltd
About ABATEAS (Abateas Industries Ltd)
Abateas Industries Ltd is a multifaceted healthcare entity making significant strides within hospital environments. Imagine stepping into a state-of-the-art eye clinic, where the p...recision of diagnostic equipment meets the compassionate care of specialized ophthalmologists. Abateas integrates seamlessly into this setting, providing advanced surgical tools for delicate procedures like cataract removal and laser vision correction. Their unwavering commitment to quality shines through in every aspect, from the sterile packaging of surgical instruments to the ergonomic design of examination chairs. Abateas also plays a pivotal role in equipping hospital pharmacies with a comprehensive range of ophthalmic medications and solutions, ensuring patients receive the treatments they need. Furthermore, Abateas invests heavily in continuous medical education for hospital staff, facilitating the seamless integration of new technologies and protocols. Within hospital infrastructure, Abateas extends its expertise beyond direct patient care. Their innovative architectural division collaborates with hospital administrators to design and optimize patient flow, maximizing efficiency and minimizing patient wait times. Consider the carefully planned layout of a new oncology ward, or the thoughtful redesign of an existing emergency department to enhance accessibility and functionality. Moreover, their business advisory team assists hospitals in navigating the complexities of healthcare finance and compliance, offering guidance on matters ranging from resource allocation to regulatory reporting. Abateas strives to be a trusted partner, working to make sure hospitals deliver the best possible patient outcomes within sustainable operational frameworks. Crucially, Abateas Industries Ltd acknowledges that comprehensive healthcare hinges on a holistic approach. To this end, their educational arm develops bespoke training programs for nurses, technicians, and other allied health professionals working in hospital settings. These programs emphasize practical skills, evidence-based practices, and the importance of patient-centered care. Think of the newly trained surgical nurse efficiently assisting in a complex cardiac operation, or the medical technician skillfully operating advanced imaging equipment. By investing in the professional growth of hospital staff, Abateas plays a crucial role in fostering a culture of excellence and continuous improvement within the wider healthcare ecosystem.
Company Details
Key Leadership
Latest News
ABATEAS Share Price: Frequently Asked Questions
What is the current share price of Abateas Industries Ltd?
Abateas Industries Ltd (ABATEAS) trades at ₹10.88 on NSE and BSE. Market cap ₹263.20 (Cr). Educational data only.
What is the P/E ratio of Abateas Industries Ltd?
Abateas Industries Ltd has a P/E of 50.62x vs industry average 52.84x.
What is the Bull Run score for Abateas Industries Ltd?
Abateas Industries Ltd has a Bull Run score of 14.9/100 based on 25+ financial parameters.
Does Abateas Industries Ltd pay dividends?
Abateas Industries Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Abateas Industries Ltd?
Abateas Industries Ltd has ROE of N/A. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Abateas Industries Ltd?
Abateas Industries Ltd has debt-to-equity of 0.05.
Is Abateas Industries Ltd a good investment?
Bull Run gives Abateas Industries Ltd a score of 14.9/100. This is not investment advice — consult a SEBI-registered advisor.